Lung cancer cell lines as tools for biomedical discovery and research
- PMID: 20679594
- PMCID: PMC2935474
- DOI: 10.1093/jnci/djq279
Lung cancer cell lines as tools for biomedical discovery and research
Abstract
Lung cancer cell lines have made a substantial contribution to lung cancer translational research and biomedical discovery. A systematic approach to initiating and characterizing cell lines from small cell and non-small cell lung carcinomas has led to the current collection of more than 200 lung cancer cell lines, a number that exceeds those for other common epithelial cancers combined. The ready availability and widespread dissemination of the lines to investigators worldwide have resulted in more than 9000 citations, including multiple examples of important biomedical discoveries. The high (but not perfect) genomic similarities between lung cancer cell lines and the lung tumor type from which they were derived provide evidence of the relevance of their use. However, major problems including misidentification or cell line contamination remain. Ongoing studies and new approaches are expected to reveal the full potential of the lung cancer cell line panel.
Figures
Similar articles
-
[Anti-angiogenic factors in thoracic oncology: successes, failures and prospects].Rev Mal Respir. 2011 Dec;28(10):1216-29. doi: 10.1016/j.rmr.2011.04.014. Epub 2011 Nov 4. Rev Mal Respir. 2011. PMID: 22152931 Review. French.
-
Comprehensive Pharmacogenomic Profiling of Malignant Pleural Mesothelioma Identifies a Subgroup Sensitive to FGFR Inhibition.Clin Cancer Res. 2018 Jan 1;24(1):84-94. doi: 10.1158/1078-0432.CCR-17-1172. Epub 2017 Oct 23. Clin Cancer Res. 2018. PMID: 29061644
-
Human lung-derived mesenchymal stem cell-conditioned medium exerts in vitro antitumor effects in malignant pleural mesothelioma cell lines.Stem Cell Res Ther. 2016 Feb 9;7:25. doi: 10.1186/s13287-016-0282-7. Stem Cell Res Ther. 2016. PMID: 26861734 Free PMC article.
-
Eve of the third millennium, providing an update on the management of non-small cell lung cancer (NSCLC).Anticancer Drugs. 2001 Jul;12 Suppl 3:S1. Anticancer Drugs. 2001. PMID: 11556248 English, French. No abstract available.
-
Antibody drug conjugates in thoracic malignancies.Lung Cancer. 2018 Oct;124:260-269. doi: 10.1016/j.lungcan.2018.07.001. Epub 2018 Jul 19. Lung Cancer. 2018. PMID: 30268471 Review.
Cited by
-
Relating hepatocellular carcinoma tumor samples and cell lines using gene expression data in translational research.BMC Med Genomics. 2015;8 Suppl 2(Suppl 2):S5. doi: 10.1186/1755-8794-8-S2-S5. Epub 2015 May 29. BMC Med Genomics. 2015. PMID: 26043652 Free PMC article.
-
Establishment and identification of human primary lung cancer cell culture in vitro.Int J Clin Exp Pathol. 2015 Jun 1;8(6):6540-6. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26261533 Free PMC article.
-
Jumonji Inhibitors Overcome Radioresistance in Cancer through Changes in H3K4 Methylation at Double-Strand Breaks.Cell Rep. 2018 Oct 23;25(4):1040-1050.e5. doi: 10.1016/j.celrep.2018.09.081. Cell Rep. 2018. PMID: 30355483 Free PMC article.
-
Apoptosis Induction of Agave lechuguilla Torrey Extract on Human Lung Adenocarcinoma Cells (SK-LU-1).Int J Mol Sci. 2018 Nov 27;19(12):3765. doi: 10.3390/ijms19123765. Int J Mol Sci. 2018. PMID: 30486412 Free PMC article.
-
Systematic identification of molecular subtype-selective vulnerabilities in non-small-cell lung cancer.Cell. 2013 Oct 24;155(3):552-66. doi: 10.1016/j.cell.2013.09.041. Epub 2013 Oct 24. Cell. 2013. PMID: 24243015 Free PMC article.
References
-
- Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100(1):57–70. - PubMed
-
- Weed D. Methodologic guidelines for review papers. J Natl Cancer Inst. 1997;89(1):6–7.
-
- Lucey BP, Nelson-Rees WA, Hutchins GM. Henrietta Lacks, HeLa cells, and cell culture contamination. Arch Pathol Lab Med. 2009;133(9):1463–1467. - PubMed
-
- Nelson-Rees WA, Zhdanov VM, Hawthorne PK, Flandermeyer RR. HeLa-like marker chromosomes and type-A variant glucose-6-phosphate dehydrogenase isoenzyme in human cell cultures producing Mason-Pfizer monkey virus-like particles. J Natl Cancer Inst. 1974;53(3):751–757. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials